Causes and Management of Persistent Supraventricular Tachycardia (SVT)

Introduction to Persistent SVT

Persistent SVT lasting weeks to months is most commonly caused by underlying structural heart disease, metabolic disorders, or uncontrolled re-entrant circuits, with the critical concern being the development of tachycardia-mediated cardiomyopathy from prolonged fast ventricular rates 1, 2

The American Heart Association suggests that re-entry circuits are the most common mechanism, involving repetitive electrical impulse conduction around a fixed obstacle requiring unidirectional conduction block and slow conduction for maintenance 3
Abnormal automaticity, enhanced diastolic phase 4 depolarization in atrial, AV junctional, or atrial vessel tissues, can lead to increased firing rates 3
Triggered activity, disturbances in repolarization where afterdepolarizations reach threshold and trigger early action potentials, is another mechanism 3

Nonparoxysmal Junctional Tachycardia is characterized by narrow complex tachycardia with rates of 70-120 bpm, showing "warm-up" and "cool-down" patterns, and may be caused by digitalis toxicity, postcardiac surgery, hypokalemia, myocardial ischemia, chronic obstructive lung disease with hypoxia, or inflammatory myocarditis 4
Permanent Form of Junctional Reciprocating Tachycardia (PJRT) is a rare clinical syndrome involving a slowly conducting, concealed, usually posteroseptal accessory pathway, characterized by incessant SVT with negative P waves in leads II, III, and aVF and long RP interval (RP > PR) 4
Atrial Tachycardia can be caused by enhanced automaticity, triggered activity, or micro-reentry within atrial tissue, and multifocal atrial tachycardia (MAT) is most commonly encountered in patients with pulmonary disease 1, 2, 3
Atrial Flutter is a macro-reentrant circuit typically around the tricuspid annulus, often associated with structural heart disease or precipitating events 3

The American College of Cardiology recommends considering heart failure, hypertension, valvular disease, and hypertrophic cardiomyopathy as predisposing factors for persistent SVT 1, 3
Congenital heart disease, particularly Ebstein anomaly, Tetralogy of Fallot, transposition of great arteries, and atrial septal defects, carries a high risk of SVT, with an incidence of 10-20% in adults with congenital heart disease 5, 6
Acute precipitating events, such as major surgery, pneumonia, acute myocardial infarction, hyperthyroidism, electrolyte abnormalities, and infection or volume loss, can contribute to the development of persistent SVT 1, 3
Medications and substances, including stimulants, antiarrhythmics, caffeine, and digitalis, can also precipitate persistent SVT 3, 4

Tachycardia-mediated cardiomyopathy is a critical concern, developing when SVT persists for weeks to months with a fast ventricular response 1, 2, 6
Additional complications include heart failure, pulmonary edema, myocardial ischemia, syncope, stroke risk, and sudden cardiac death 1, 2, 5, 6

The American Heart Association recommends immediate evaluation priorities, including identifying and correcting underlying causes, obtaining a 12-lead ECG during tachycardia, and performing an echocardiogram to assess for structural heart disease and ventricular function 1, 2, 4
Specific management by etiology, including withholding digitalis, considering digitalis-binding agents, using beta blockers or calcium-channel blockers, and atrial pacing, may be necessary for nonparoxysmal junctional tachycardia 4
For persistent re-entrant tachycardias, catheter ablation is a first-line definitive therapy, with success rates of 94.3-98.5% 5
For congenital heart disease patients, management must be undertaken in collaboration with a cardiologist with specialized training, and catheter ablation success rates are lower, with higher recurrence rates 5

Never miss digitalis toxicity as the cause of persistent junctional tachycardia, as this is the most important reversible cause 4
Do not use flecainide in patients with structural heart disease or recent myocardial infarction due to proarrhythmic risk 5
Always evaluate for pre-excitation on baseline ECG, as patients with accessory pathways developing atrial fibrillation are at risk for sudden death and require immediate electrophysiological evaluation 1, 2, 3
Do not delay echocardiography, as persistent SVT may both cause and be caused by cardiomyopathy 1, 2, 6